Not all clients with CLL require therapy. Inspite of all new developments, the iwCLL however recommends watchful observation for clients with asymptomatic ailment.86 This recommendation is based on at the very least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).War